Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 696 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Neoadjuvant Pertuzumab/Trastuzumab Demonstrates Long-Term Cardiac Safety in HER2-Positive Breast Cancer May 7, 2021 Zanubrutinib’s Approval Improves Targeted Treatment for CLL January 27, 2023 Why ASCO’s Annual Meeting Matters for People With Cancer and How... June 1, 2021 How serendipity sent this oncologist in search of a cure for... August 12, 2022 Load more HOT NEWS Ranking of Molecular Alterations in HNSCC According to ESCAT Classification Provides... For Women With Dense Breasts, An MRI May Be A Better... New 5-Minute Injection Reduces Time Breast Cancer Patients Spend in Treatment EMA Recommends to Extend the Indications for Tislelizumab
